P74 Bio is a Boston-based investment credit fund providing multi-year debt financing to clinical-stage biotech and medical device companies conducting clinical trials in Australia.

We offer R&D financing up to 35% of the estimated costs of one or more trials (Phase I–III), giving companies a flexible, non-dilutive capital solution that advances their clinical development programs.

Our mission is to empower innovators to stay focused on what matters most - delivering transformative therapies to patients.